References
- Fatima Z, Sharma P, Youssef B, Krishnan K. Medullary Carcinoma of the Colon: A Histopathologic Challenge. Cureus. 2021 Jun 22;13(6):e15831. doi: 10.7759/cureus.15831.
- Jabbal IS, Nagarajan A, Rivera C, Yaghi M, Liang H, Nahleh Z, et al. Medullary carcinoma of the colon: A comprehensive analysis of the National Cancer Database. Surg Oncol. 2022 Dec;45:101856. doi: 10.1016/j.suronc.2022.101856. Epub 2022 Sep 29.
- Scott N, West NP, Cairns A, Rotimi O: Is medullary carcinoma of the colon underdiagnosed? An audit of poorly differentiated colorectal carcinomas in a large national health service teaching hospital. Histopathology. 2021, 78:963–969. 10.1111/his.14310
- Al-Ishaq F, Al-Dhaheri M, Toffaha A, Awad S, Rizvi S, AbuNada M, et al. Colonic medullary carcinoma: an exceedingly rare type of colorectal malignancy: a case report and review of the literature. J Med Case Rep. 2023 Nov 1;17(1):483. doi: 10.1186/s13256-023-04228-x.
- Kai K, Hidaka H, Nakamura T, Ueda Y, Marutsuka K, Ikeda T, et al. A case of poorly differentiated adenocarcinoma with lymphoid stroma originated in the ascending colon diagnosed as lymphoepithelioma-like carcinoma. Clin J Gastroenterol. 2020 Aug;13(4):538–544. doi: 10.1007/s12328-019-01081-8. Epub 2019 Dec 16.
- Winn B, Tavares R, Fanion J, Noble L, Gao J, Sabo E, et al: Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation. Hum Pathol. 2009, 40:398–404. doi: 10.1016/j.humpath.2008.08.014. Epub 2008 Nov 7.
- Colarossi C, Mare M, La Greca G, De Zuanni M, Colarossi L, Aiello E, et al. Medullary Carcinoma of the Gastrointestinal Tract: Report on Two Cases with Immunohistochemical and Molecular Features. Diagnostics (Basel). 2021 Sep 27;11(10):1775. doi: 10.3390/diagnostics11101775.
- Blakely AM, Nelson RA, Hamilton SA, Lai LL: Sidedness determines clinical characteristics and survival outcomes in medullary adenocarcinoma of the colon. Sci Rep. 2021, 14:20481. doi: 10.1038/s41598-021-99848-y.
- Baxter NN, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, et al. Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update. J Clin Oncol. 2022 Mar 10;40(8):892–910. doi: 10.1200/JCO.21.02538. Epub 2021 Dec 22.
- Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003 Jul 17;349(3):247–57. doi: 10.1056/NEJMoa022289.
- Friedman K, Brodsky AS, Lu S, Wood S, Gill AJ, Lombardo K, et al. Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment. Mod Pathol. 2016 May;29(5):528–41. doi: 10.1038/modpathol.2016.54. Epub 2016 Mar 11.